IMR Press / CEOG / Volume 13 / Issue 1-2 / pii/1634257597524-462770875

Clinical and Experimental Obstetrics & Gynecology (CEOG) is published by IMR Press from Volume 46 Issue 1 (2019). Previous articles were published by another publisher on a subscription basis, and they are hosted by IMR Press on as a courtesy and upon agreement with S.O.G.

Open Access Original Research
Endometrial hormonal receptors as marker of benign breast disease (B.B.D.)
Show Less
1 Institute of Obstet. Gynec. - University of Padua (Italy)
Clin. Exp. Obstet. Gynecol. 1986, 13(1-2), 5–9;
Published: 10 March 1986

The problem of hormonal treatment of benign disease and mastodynia is still dividing Clinicians and Researchers. The Authors, in order to select the patients suitable to be treated, propose the assay of Estradiol and Progesterone Receptors in the most accessible hormone-dependent tissue: the Endometrium. Author's data point out a quite different behaviour of Estradiol and Progesterone cytoplasmic receptors in the Endometrium of women with B.B.D. and controls. The knowledge of this information in the single patients will release from subjectivity when deciding about B.B.D. therapy or when trying to correct unsatisfactory treatment.
Back to top